Broadcom
AVGO
Salesforce
CRM
Qualcomm
QCOM
4
Oracle
ORCL
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
STOK Stoke Therapeutics
- 9.880
- +0.360+3.78%
Close Apr 24 16:00 ET
- 9.880
- 0.0000.00%
Post 16:37 ET
539.42MMarket Cap-5.99P/E (TTM)
9.900High9.461Low602.77KVolume9.490Open9.520Pre Close5.85MTurnover1.60%Turnover RatioLossP/E (Static)54.60MShares17.58052wk High2.36P/B372.11MFloat Cap5.35052wk Low--Dividend TTM37.66MShs Float71.580Historical High--Div YieldTTM4.61%Amplitude3.350Historical Low9.711Avg Price1Lot Size
Stoke Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -7.13%-86.85M | -12.33%-23.19M | -25.21%-21.62M | 19.83%-17.48M | -15.03%-24.57M | -154.40%-81.07M | 7.71%-20.65M | 21.73%-17.26M | -9.39%-21.8M | -165.73%-21.36M |
| Net income from continuing operations | 15.01%-88.98M | 61.12%-10.48M | -7.69%-26.43M | 16.18%-25.7M | -16.98%-26.37M | -3.59%-104.7M | -5.08%-26.96M | 6.01%-24.54M | -24.35%-30.65M | 8.54%-22.55M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | --1K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -11.83%2.18M | -15.71%526K | -15.23%540K | -10.31%548K | -5.70%563K | 59.70%2.47M | 2.46%624K | 64.18%637K | 102.32%611K | 141.70%597K |
| Other non cash items | 0.22%2.27M | -1.36%582K | 1.24%571K | 1.08%562K | 0.00%550K | 13.62%2.26M | 8.66%590K | 5.22%564K | 4.32%556K | 45.89%550K |
| Change In working capital | -366.67%-28.14M | -2,205.83%-20.18M | -823.93%-3.24M | -102.80%-30K | 20.18%-4.69M | -114.02%-6.03M | 75.06%-875K | 86.97%-351K | 151.56%1.07M | -111.45%-5.88M |
| -Change in prepaid assets | -447.07%-1.84M | -206.65%-1.44M | 216.73%600K | -136.22%-644K | 83.29%-349K | 110.21%529K | 188.55%1.35M | -188.47%-514K | 283.11%1.78M | 36.05%-2.09M |
| -Change in payables and accrued expense | 196.26%3.09M | 289.64%2.18M | -137.13%-749K | 180.80%3.58M | -646.72%-1.92M | 9.12%-3.21M | -677.39%-1.15M | 249.85%2.02M | -517.64%-4.43M | 110.19%351K |
| -Change in other working capital | -777.11%-29.39M | -1,838.09%-20.91M | -66.88%-3.09M | -179.61%-2.96M | 41.47%-2.42M | -106.48%-3.35M | 50.50%-1.08M | 3.84%-1.85M | 271.52%3.72M | -107.14%-4.14M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -7.13%-86.85M | -12.32%-23.19M | -25.22%-21.62M | 19.83%-17.48M | -15.03%-24.57M | -154.40%-81.07M | 7.71%-20.65M | 21.74%-17.26M | -9.39%-21.8M | -165.73%-21.36M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -201.44%-107.48M | -94.46%819K | -305.27%-30M | -476.08%-88.28M | -81.18%9.99M | 330.91%105.95M | -34.32%14.77M | -78.27%14.62M | 15,977.40%23.47M | 139.10%53.09M |
| Net PPE purchase and sale | 87.44%-203K | 81.66%-42K | 73.11%-103K | 94.52%-46K | 92.73%-12K | 59.21%-1.62M | 44.01%-229K | 81.13%-383K | -23.02%-839K | 80.38%-165K |
| Net investment purchase and sale | -199.73%-107.27M | -94.26%861K | -299.34%-29.9M | -462.92%-88.23M | -81.22%10M | 356.59%107.56M | -34.49%15M | -78.35%15M | 2,836.23%24.31M | 139.46%53.25M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -201.44%-107.48M | -94.46%819K | -305.27%-30M | -476.08%-88.28M | -81.18%9.99M | 330.91%105.95M | -34.32%14.77M | -78.27%14.62M | 15,977.40%23.47M | 139.10%53.09M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 147.31%131.09M | -92.26%568K | 1,351.78%8.16M | 251,254.17%120.65M | -96.19%1.72M | 14.22%53.01M | 16,976.74%7.34M | 29.49%562K | -98.60%48K | 5.99%45.05M |
| Net common stock issuance | 147.38%128.84M | -99.99%1K | --7.66M | --119.88M | -97.10%1.3M | 14.86%52.08M | --7.34M | --0 | --0 | 5.91%44.74M |
| Proceeds from stock option exercised by employees | 143.41%2.25M | 11,240.00%567K | -10.50%503K | 1,495.83%766K | 34.41%418K | -12.97%926K | -88.10%5K | 29.49%562K | -85.28%48K | 18.70%311K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 147.31%131.09M | -92.26%568K | 1,351.78%8.16M | 251,254.17%120.65M | -96.19%1.72M | 14.22%53.01M | 16,976.74%7.34M | 29.49%562K | -98.60%48K | 5.99%45.05M |
| Net cash flow | ||||||||||
| Beginning cash position | 68.25%192.01M | -20.97%150.59M | 0.74%194.05M | -6.16%179.15M | 68.25%192.01M | -21.54%114.13M | 67.20%190.55M | 181.94%192.63M | 125.45%190.91M | -21.54%114.13M |
| Current changes in cash | -181.19%-63.23M | -1,588.46%-21.81M | -1,986.41%-43.46M | 765.49%14.9M | -116.75%-12.86M | 348.53%77.89M | 815.63%1.47M | -104.56%-2.08M | 110.52%1.72M | 226.32%76.78M |
| End cash Position | -32.93%128.78M | -32.93%128.78M | -20.97%150.59M | 0.74%194.05M | -6.16%179.15M | 68.25%192.01M | 68.25%192.01M | 67.20%190.55M | 181.94%192.63M | 125.45%190.91M |
| Free cash flow | -5.29%-87.05M | -11.29%-23.24M | -23.08%-21.72M | 22.60%-17.52M | -14.20%-24.58M | -130.78%-82.68M | 8.36%-20.88M | 26.74%-17.65M | -9.84%-22.64M | -168.00%-21.52M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀